Chang Yao-Jen, Chung Kuo-Piao, Chen Li-Ju, Chang Yun-Jau
From the Department of Surgery (Yao-Jen Chang), Taipei Branch, Buddhist Tzu Chi General Hospital; Graduate Institute of Health Policy and Management (K-PC, L-JC), College of Public Health, National Taiwan University; Department of Ophthalmology (L-JC), HepingFuyou Branch; Department of General Surgery (Yun-Jau Chang), Zhong-Xing Branch, Taipei City Hospital; and Department of General Surgery (Yun-Jau Chang), National Taiwan University Hospital, Taipei, Taiwan.
Medicine (Baltimore). 2015 Jan;94(1):e208. doi: 10.1097/MD.0000000000000208.
Lymph node ratio (LNR) is a powerful prognostic factor for breast cancer. We conducted a recursive partitioning analysis (RPA) of the LNR to identify the prognostic risk groups in breast cancer patients. Records of newly diagnosed breast cancer patients between 2002 and 2006 were searched in the Taiwan Cancer Database. The end of follow-up was December 31, 2009. We excluded patients with distant metastases, inflammatory breast cancer, survival <1 month, no mastectomy, or missing lymph node status. Primary outcome was 5-year overall survival (OS). For univariate significant predictors, RPA were used to determine the risk groups. Among the 11,349 eligible patients, we identified 4 prognostic factors (including LNR) for survival, resulting in 8 terminal nodes. The LNR cutoffs were 0.038, 0.259, and 0.738, which divided LNR into 4 categories: very low (LNR ≤ 0.038), low (0.038 < LNR ≤ 0.259), moderate (0.259 < LNR ≤ 0.738), and high (0.738 < LNR). Then, 4 risk groups were determined as follows: Class 1 (very low risk, 8,265 patients), Class 2 (low risk, 1,901 patients), Class 3 (moderate risk, 274 patients), and Class 4 (high risk, 900 patients). The 5-year OS for Class 1, 2, 3, and 4 were 93.2%, 83.1%, 72.3%, and 56.9%, respectively (P< 0.001). The hazard ratio of death was 2.70, 4.52, and 8.59 (95% confidence interval 2.32-3.13, 3.49-5.86, and 7.48-9.88, respectively) times for Class 2, 3, and 4 compared with Class 1 (P < 0.001). In conclusion, we identified the optimal cutoff LNR values based on RPA and determined the related risk groups, which successfully predict 5-year OS in breast cancer patients.
淋巴结比率(LNR)是乳腺癌一个强有力的预后因素。我们对LNR进行了递归划分分析(RPA),以确定乳腺癌患者的预后风险组。在台湾癌症数据库中检索了2002年至2006年间新诊断乳腺癌患者的记录。随访截止于2009年12月31日。我们排除了有远处转移、炎性乳腺癌、生存期<1个月、未行乳房切除术或淋巴结状态缺失的患者。主要结局是5年总生存期(OS)。对于单变量显著预测因素,采用RPA来确定风险组。在11349例符合条件的患者中,我们确定了4个生存预后因素(包括LNR),产生了8个终末节点。LNR的截断值为0.038、0.259和0.738,这将LNR分为4类:极低(LNR≤0.038)、低(0.038<LNR≤0.259)、中度(0.259<LNR≤0.738)和高(0.738<LNR)。然后,确定4个风险组如下:1类(极低风险,8265例患者)、2类(低风险,1901例患者)、3类(中度风险,274例患者)和4类(高风险,900例患者)。1类、2类、3类和4类的5年OS分别为93.2%、83.1%、72.3%和56.9%(P<0.001)。与1类相比,2类、3类和4类的死亡风险比分别为2.70、4.52和8.59(95%置信区间分别为2.